BSE filing, BSE: 543931. Summary written from the filing by ALFA Finder's alert engine.
Veefin Solutions Ltd: key numbers
- Share price
- ₹237.00
- Market cap
- ₹605.3 Cr
- Revenue (annual)
- ₹345.1 Cr
- Net profit (annual)
- ₹22.78 Cr
- P/E (TTM)
- 26.6×Sector 23.0×
- Promoter holding
- 34.73%+0.00% QoQ
- FII holding
- 2.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Veefin Solutions Ltd
All →Veefin Solutions Results Update
Veefin reported H1 FY27 revenue of ₹238.82 Cr (up 116% YoY) and PAT of ₹24.85 Cr. The company highlighted a ₹920 Cr opportunity pipeline in banking technology.
Veefin Solutions Investor Presentation: Key Takeaways
H1 FY27 group revenue ₹238.82 cr (+116.2% YoY), PAT ₹24.85 cr (+126.6%), EBITDA margin 25.5%. Standalone Q2 PAT flat; ₹920 cr pipeline, 84% outside India.
Veefin Solutions Q2 FY27 Results: Net Profit ₹15.3 Cr, Up 61.1% QoQ
Veefin Solutions Ltd reported revenue from operations of ₹124.7 Cr and net profit of ₹15.3 Cr for Q2 FY27.
- Key figure
- Net profit ₹15.3 Cr
Veefin Solutions Acquisition
Veefin Solutions disclosed its step-down subsidiaries' board-approved amalgamation, NTPL into WRM, via a Companies Act scheme. Consideration is share-based, with no cash paid.
Veefin Solutions Board Meeting Date
Veefin Solutions has scheduled a Board meeting on October 26, 2026 to consider Q1 and H1 FY27 results. The trading window remains closed pending results declaration.
Veefin Solutions Share Pledge
Promoter Gautam Udani pledged 6,12,647 shares of Veefin Solutions as debt collateral. The revised SAST 31 disclosure names lender Stride Ventures Debt Fund 4.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.